Amazonas Florestal Ltd Announces Completion and Publication of All of Its Pending Disclosures with OTC Markets

MIAMI, FL, April 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Amazonas Florestal, Ltd.  (OTC: “AZFL”) (azflamerica.com), a natural resources company dedicated to innovative, sustainable forest management, the certification and sales of carbon credits, and processing Industrial Hemp, announced today that the Company has completed and posted all of its pending OTC Markets Disclosures and Financial Reports. OTC Markets has acknowledged publication of all of the pending Quarterly and Annual Reports beginning with the 2018 Annual Report and through the 2020 Annual Report. 

The Company announced also, that today the Company has published the Attorney Opinion Letter on Current Financials that includes a positive review of all of the disclosures posted yesterday 04.07.2021. These filings complete all of the company’s financial obligations with OTC Markets and should bring it back to current Pink Sheets Information Tier status in the coming days once OTC Markets completes their review of the filings. 

As previously reported, Green America Laboratories, a subsidiary of AZFL, has secured a facility in NW Miami-Dade County where the company will be building a top-of-the-line Hemp derived products lab that is due to begin operations sometime during the next fiscal quarter of 2021. GAL is due to become the largest Hemp processor this far south in the USA. AZFL further announced that GAL is presently in advancing negotiations to enter into an agreement that will allow the company to build a second cannabinoid bulk extractions lab in the country of Colombia and in partnership with a soon to be disclosed licensee that already operates production and distribution facilities under license to the Colombian government. AZFL will commit to increase their present operations for both Industrial Hemp and Medical Marijuana in that country, with focus on the new emerging markets in the European Union. Colombia is the only Latin American country that is approved by the European Union thus far to import and distribute cannabis products and allows licensing for the production and distribution of Delta 8 and Delta 9 products. 

Further, the Company announced that several PCAOB audit firms are being interviewed this week and the Company expects to retain one of the candidates in the coming days to complete PCAOB audits of all of its records to date with the intention of completing and filing an S1 Registration Statement. The Registration will include the registration of an IPO that will allow the company funding channels to fund its present business plans which include extraction and conversion labs in several jurisdictions.